Skip to Main Content

TMS to Treat Core Social Deficits in Autism Spectrum Disorder

  • Study HIC#:2000030576
  • Last Updated:02/22/2024

This study will evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS), a type of noninvasive brain stimulation, on the social brain. TMS is a therapy that has been approved for depression and obsessive-compulsive disorder and we are looking to see if it can also help those with ASD. This method uses magnetic waves administered in a train of pulses to influence brain activity. A participant visit includes a baseline assessment of neuropsychological, cognitive and behavioral function and an EEG and eye-tracking session to measure visual and social responses before and after TMS. 

Participation consists of 2 visits and compensation is $100 per visit. 

We are seeking participants diagnosed with autism or typical development between the ages of 18 to 30 years old.

  • Age18 years - 30 years
  • GenderBoth

Contact Us

For more information about this study, including how to volunteer, contact:

Our Team

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

Trial Purpose and Description

This study will evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS), a type of noninvasive brain stimulation, on the social brain. TMS is a therapy that has been approved for depression and obsessive-compulsive disorder and we are looking to see if it can also help those with ASD. This method uses magnetic waves administered in a train of pulses to influence brain activity. A participant visit includes a baseline assessment of neuropsychological, cognitive and behavioral function and an EEG and eye-tracking session to measure visual and social responses before and after TMS. 

Participation consists of 2 visits and compensation is $100 per visit. 

We are seeking participants diagnosed with autism or typical development between the ages of 18 to 30 years old.

Eligibility Criteria

Inclusion Criteria: 

  • Age:  18-30
  • Gender:  Both
  • Adults with diagnosis of ASD or typical development

Principal Investigator

Sub-Investigator

For more information about this study, including how to volunteer, contact: